OTC Markets EXMKT - Delayed Quote USD

Ayala Pharmaceuticals, Inc. (ADXS)

0.0401
0.0000
(0.00%)
At close: May 13 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
13
13
692
3,506
3,708
Cost of Revenue
13
13
602
3,506
3,708
Gross Profit
0
0
90
0
0
Operating Expense
36,266
36,266
37,593
39,218
29,777
Operating Income
-36,266
-36,266
-37,503
-39,218
-29,777
Net Non Operating Interest Income Expense
-15,718
-15,718
74
-260
56
Pretax Income
-51,984
-51,984
-37,429
-39,478
-29,721
Tax Provision
-3,912
-3,912
584
776
425
Net Income Common Stockholders
-48,072
-48,072
-38,013
-40,254
-30,146
Diluted NI Available to Com Stockholders
-48,072
-48,072
-38,013
-40,254
-30,146
Basic EPS
-7.99
-7.99
-13.13
-2.80
-3.06
Diluted EPS
-7.99
-7.99
-13.13
-2.80
-3.06
Basic Average Shares
6,019.0630
6,019.0630
2,895.1300
14,398.9050
9,860.6100
Diluted Average Shares
6,019.0630
6,019.0630
2,895.1300
14,398.9050
9,860.6100
Total Operating Income as Reported
-36,266
-36,266
-37,503
-39,218
-29,777
Total Expenses
36,279
36,279
38,195
42,724
33,485
Net Income from Continuing & Discontinued Operation
-48,072
-48,072
-38,013
-40,254
-30,146
Normalized Income
-48,072
-48,072
-38,013
-40,254
-30,146
Interest Income
28
28
74
--
56
Interest Expense
15,746
15,746
0
260
--
Net Interest Income
-15,718
-15,718
74
-260
56
EBIT
-36,238
-36,238
-37,429
-39,218
-29,777
EBITDA
-35,869
-35,869
-37,267
-39,050
-29,595
Reconciled Cost of Revenue
13
13
602
3,506
3,708
Reconciled Depreciation
369
369
162
168
182
Net Income from Continuing Operation Net Minority Interest
-48,072
-48,072
-38,013
-40,254
-30,146
Normalized EBITDA
-35,869
-35,869
-37,267
-39,050
-29,595
Tax Rate for Calcs
0.0001
0.0001
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 5/8/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AMBS Amarantus BioScience Holdings, Inc.
0.0003
0.00%
 
ATXI Avenue Therapeutics, Inc.
0.2400
+36.99%
 
NBY NovaBay Pharmaceuticals, Inc.
0.5950
+1.28%
 
PXMD PaxMedica, Inc.
0.0001
0.00%
 
TRAW Traws Pharma, Inc.
1.2400
+1.64%
 
OKYO OKYO Pharma Limited
1.3400
-6.29%
 
ENTO Entero Therapeutics, Inc.
0.4180
+3.47%
 
DB0.F Q32 Bio Inc.
1.5000
+4.17%
 
ALLK Allakos Inc.
0.3291
-0.06%
 
ANTH Anthera Pharmaceuticals, Inc.
0.0001
0.00%